Micronutrient Deficiencies in Systemic Sclerosis: A Scoping Review

References

• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–1699. doi:10.1016/S0140-6736(17)30933-9
   PubMed Web of Science ®Google Scholar
• Poudel DR, Derk CT. Mortality and survival in systemic sclerosis: a review of recent literature. Curr Opin Rheumatol. 2018;30(6):588–593. doi:10.1097/BOR.0000000000000551
   PubMed Web of Science ®Google Scholar
• Franck-Larsson K, Graf W, Rönnblom A. Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study. Eur J Gastroenterol Hepatol. 2009;21(2):176–182. doi:10.1097/MEG.0b013e32831dac75
   PubMed Web of Science ®Google Scholar
• McFarlane IM, Bhamra MS, Kreps A, et al. Gastrointestinal manifestations of systemic sclerosis. Rheumatology. 2018;8. doi:10.4172/2161-1149.1000235
   PubMedGoogle Scholar
• Sallam H, McNearney TA, Chen JDZ. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006;23(6):691–712. doi:10.1111/j.1365-2036.2006.02804.x
   PubMed Web of Science ®Google Scholar
• Nagaraja V, McMahan ZH, Getzug T, Khanna D. Management of gastrointestinal involvement in scleroderma. Curr Treat Options Rheumatol. 2015;1(1):82–105. doi:10.1007/s40674-014-0005-0
   PubMedGoogle Scholar
• McMahan ZH, Paik JJ, Wigley FM, Hummers LK. Determining the risk factors and clinical features associated with severe gastrointestinal dysmotility in systemic sclerosis. Arthritis Care Res. 2018;70(9):1385–1392. doi:10.1002/acr.23479
   Web of Science ®Google Scholar
• Volkmann ER, Chang YL, Barroso N, et al. Association of systemic sclerosis with a unique colonic microbial consortium. Arthritis Rheumatol. 2016;68(6):1483–1492. doi:10.1002/art.39572
   PubMed Web of Science ®Google Scholar
• Caporali R, Caccialanza R, Bonino C, et al. Disease-related malnutrition in outpatients with systemic sclerosis. Clin Nutr. 2012;31(5):666–671. doi:10.1016/j.clnu.2012.02.010
   PubMed Web of Science ®Google Scholar
• Harrison E, Herrick AL, McLaughlin JT, Lal S. Malnutrition in systemic sclerosis. Rheumatology. 2012;51(10):1747–1756. doi:10.1093/rheumatology/kes160
   PubMed Web of Science ®Google Scholar
• Baron M, Hudson M, Steele R, et al. Malnutrition is common in systemic sclerosis: results from the Canadian Scleroderma Research Group database. J Rheumatol. 2009;36(12):2737–2743. doi:10.3899/jrheum.090694
   PubMed Web of Science ®Google Scholar
• Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437–2444. doi:10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Bodukam V, Hays RD, Maranian P, et al. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology. 2011;50(2):330–334. doi:10.1093/rheumatology/keq296
   PubMed Web of Science ®Google Scholar
• Omair MA, Lee P. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis. J Rheumatol. 2012;39(5):992–996. doi:10.3899/jrheum.110826
   PubMed Web of Science ®Google Scholar
• Preis E, Franz K, Siegert E, et al. The impact of malnutrition on quality of life in patients with systemic sclerosis. Eur J Clin Nutr. 2018;72(4):504–510. doi:10.1038/s41430-018-0116-z
   PubMed Web of Science ®Google Scholar
• Wan YN, Yan JW, Peng WJ, et al. Micronutrients, their potential effect on patients with systemic sclerosis. Mod Rheumatol. 2014;24(5):709–714. doi:10.3109/14397595.2013.844383
   PubMed Web of Science ®Google Scholar
• Shenkin A. Micronutrients in health and disease. Postgrad Med J. 2006;82(971):559–567. doi:10.1136/pgmj.2006.047670
   PubMed Web of Science ®Google Scholar
• Carreiro AL, Dhillon J, Gordon S, et al. The macronutrients, appetite, and energy intake. Annu Rev Nutr. 2016;36(1):73–103. doi:10.1146/annurev-nutr-121415-112624
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLOS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700
   PubMed Web of Science ®Google Scholar
• Murdaca G, Tonacci A, Negrini S, et al. Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications. Autoimmun Rev. 2019;18(9):102350. doi:10.1016/j.autrev.2019.102350
   PubMed Web of Science ®Google Scholar
• Gatenby P, Lucas R, Swaminathan A, Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol. 2013;25(2):184–191. doi:10.1097/BOR.0b013e32835cfc16
   PubMed Web of Science ®Google Scholar
• Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. In: In: StatPearls [Internet]. StatPearls Publishing; 2021.
   Google Scholar
• Trombetta AC, Smith V, Gotelli E, et al. Vitamin D deficiency and clinical correlations in systemic sclerosis patients: a retrospective analysis for possible future developments. PLoS One. 2017;12(6):1–13. doi:10.1371/journal.pone.0179062
   Web of Science ®Google Scholar
• Sampaio-Barros MM, Takayama L, Sampaio-Barros PD, Bonfá E, Pereira RMR. Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings. Rev Bras Reumatol. 2016;56(4):337–344. doi:10.1016/j.rbre.2016.05.006
   Google Scholar
• Caramaschi P, Dalla Gassa A, Ruzzenente O, et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol. 2010;29(12):1419–1425. doi:10.1007/s10067-010-1478-3
   PubMed Web of Science ®Google Scholar
• Rios-Fernández R, Callejas-Rubio JL, Fernández-Roldán C, et al. Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions. Clin Exp Rheumatol. 2012;30(6):905–911.
   PubMed Web of Science ®Google Scholar
• Braun-Moscovici Y, Furst DE, Markovits D, et al. Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol. 2008;35(11):2201–2205. doi:10.3899/jrheum.071171
   PubMed Web of Science ®Google Scholar
• Grabowski G, Grant JP. Nutritional support in patients with systemic scleroderma. J Parenter Enter Nutr. 1989;13(2):147–151. doi:10.1177/0148607189013002147
   PubMed Web of Science ®Google Scholar
• Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol. 2009;36(9):1924–1929. doi:10.3899/jrheum.081287
   PubMed Web of Science ®Google Scholar
• Giuggioli D, Colaci M, Cassone G, et al. Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin Rheumatol. 2017;36(3):583–590. doi:10.1007/s10067-016-3535-z
   PubMed Web of Science ®Google Scholar
• Paolino S, Pacini G, Schenone C, et al. Nutritional status and bone microarchitecture in a cohort of systemic sclerosis patients. Nutrients. 2020;12(6):1–10. doi:10.3390/nu12061632
   Web of Science ®Google Scholar
• Gambichler T, Chrobok I, Höxtermann S, Kreuter A. Significantly decreased serum 25-hydroxyvitamin D levels in a large German systemic sclerosis cohort. J Rheumatol. 2011;38(11):2492LP–2493 . doi:10.3899/jrheum.110695
   Web of Science ®Google Scholar
• An L, Sun MH, Chen F, Li JR. Vitamin D levels in systemic sclerosis patients: a meta-analysis. Drug Des Devel Ther. 2017;11:3119–3125. doi:10.2147/DDDT.S144860
   PubMed Web of Science ®Google Scholar
• Zhang L, Duan Y, Zhang TP, et al. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int J Rheum Dis. 2017;20(8):1002–1008. doi:10.1111/1756-185X.12794
   PubMed Web of Science ®Google Scholar
• Corrado A, Colia R, Mele A, et al. Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) vitamin D serum levels in systemic sclerosis. PLoS One. 2015;10(9):e0137912–e0137912. doi:10.1371/journal.pone.0137912
   PubMed Web of Science ®Google Scholar
• Seriolo B, Molfetta L, Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin Rheumatol. 2011;30(3):445–446. doi:10.1007/s10067-011-1684-7
   PubMed Web of Science ®Google Scholar
• Calzolari G, Data V, Carignola R, Angeli A. Hypovitaminosis D in systemic sclerosis. J Rheumatol. 2009;36(12):2844LP–2844 . doi:10.3899/jrheum.090439
   Web of Science ®Google Scholar
• Groseanu L, Bojinca V, Gudu T, et al. Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur J Rheumatol. 2016;3(2):50–55. doi:10.5152/eurjrheum.2015.0065
   PubMedGoogle Scholar
• Arnson Y, Amital H, Agmon-Levin N, et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev. 2011;10(8):490–494. doi:10.1016/j.autrev.2011.02.002
   PubMed Web of Science ®Google Scholar
• Ahmadi R, Hajialilo M, Ghorbanihaghjo A, et al. FGF-23, klotho and vitamin D levels in scleroderma. Iran J Public Health. 2017;46(4):530–536.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mahajan VK, Yadav RS, et al. Evaluation of serum vitamin D levels in patients with systemic sclerosis and healthy controls: results of a pilot study. Indian Dermatol Online J. 2018;9(4):250–255. doi:10.4103/idoj.IDOJ_328_17
   PubMedGoogle Scholar
• Park EK, Park JH, Kweon SM, Kim GT, Lee SG. Vitamin D deficiency is associated with digital ulcer but not with atherosclerosis or arterial stiffness in patients with systemic sclerosis: a pilot study. Clin Rheumatol. 2017;36(6):1325–1333. doi:10.1007/s10067-017-3622-9
   PubMed Web of Science ®Google Scholar
• Atteritano M, Santoro D, Corallo G, et al. Skin involvement and pulmonary hypertension are associated with vitamin D insufficiency in scleroderma. Int J Mol Sci. 2016;17(12):1–8. doi:10.3390/ijms17122103
   Web of Science ®Google Scholar
• Ibn Yacoub Y, Amine B, Laatiris A, Wafki F, Znat F, Hajjaj-Hassouni N. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int. 2012;32(10):3143–3148. doi:10.1007/s00296-011-2150-1
   PubMed Web of Science ®Google Scholar
• Hax V, Gasparin AA, Schneider L, et al. Vitamin D and cytokine profiles in patients with systemic sclerosis. JCR J Clin Rheumatol. 2019;1:548.
   Google Scholar
• Caimmi C, Bertoldo E, Pozza A, et al. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: a longitudinal study. Int J Rheum Dis. 2019;22(6):1041–1045. doi:10.1111/1756-185X.13554
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Martinelli N, Biasi D, et al. Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol. 2003;30(2):298–304.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Zhang L, Huang XL, Duan Y, Yang LJ, Wang J. The association between homocysteine and systemic sclerosis: a review of the literature and meta-analysis. Mod Rheumatol. 2018;28(4):681–689. doi:10.1080/14397595.2017.1386844
   PubMed Web of Science ®Google Scholar
• O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010;2(3):299–316. doi:10.3390/nu2030299
   PubMed Web of Science ®Google Scholar
• Fratoni V, Brandi ML. B vitamins, homocysteine and bone health. Nutrients. 2015;7(4):2176–2192. doi:10.3390/nu7042176
   PubMed Web of Science ®Google Scholar
• Ankar A, Kumar A. Vitamin B12 Deficiency. In: StatPearls [Internet]. StatPearls Publishing; 2021.
   Google Scholar
• Nazarinia M, Shams M, Sarvestani EK, Shenavande S, Khademalhosseini M, Khademalhosseini Z. Serum homocysteine level in patients with scleroderma. Iran Red Crescent Med J. 2013;15(1):29–31. doi:10.5812/ircmj.3672
   PubMed Web of Science ®Google Scholar
• Tas Kilic D, Akdogan A, Kilic L, et al. Evaluation of vitamin B12 deficiency and associated factors in patients with systemic sclerosis. J Clin Rheumatol. 2018;24(5):250–254. doi:10.1097/RHU.0000000000000686
   PubMed Web of Science ®Google Scholar
• Läubli J, Dobrota R, Maurer B, et al. Impaired micronutrients and prealbumin in patients with established and very early systemic sclerosis. Clin Exp Rheumatol. 2020;29(3):120–126.
   Google Scholar
• Marasini B, Casari S, Bestetti A, et al. Homocysteine concentration in primary and systemic sclerosis associated Raynaud’s phenomenon. J Rheumatol. 2000;27(11):2621–2623.
   PubMed Web of Science ®Google Scholar
• Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–685. doi:10.1002/jimd.12009
   PubMed Web of Science ®Google Scholar
• Abosamak N, Gupta V. Vitamin B6 (Pyridoxine). StatPearls Publishing; 2021.
   Google Scholar
• Dupont R, Longué M, Galinier A, et al. Impact of micronutrient deficiency & malnutrition in systemic sclerosis: cohort study and literature review. Autoimmun Rev. 2018;17(11):1081–1089. doi:10.1016/j.autrev.2018.05.010
   PubMed Web of Science ®Google Scholar
• Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017;14(1):78. doi:10.1186/s12986-017-0233-z
   PubMed Web of Science ®Google Scholar
• Au K, Singh MK, Bodukam V, et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum. 2011;63(7):2078–2090. doi:10.1002/art.30380
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Sanguankeo A, Upala S. Risk of ischemic stroke in patients with systemic sclerosis: a systematic review and meta-analysis. Mod Rheumatol. 2016;26(1):128–131. doi:10.3109/14397595.2015.1056931
   PubMed Web of Science ®Google Scholar
• Nazarinia M, Zare A, Fallahi MJ, Shams M. Association of serum homocysteine level and interstitial lung disease in systemic sclerosis: a case-control study. Curr Rheumatol Rev. 2019;15(1):74–78. doi:10.2174/1573397114666180628162907
   PubMed Web of Science ®Google Scholar
• Szamosi S, Csiki Z, Szomják E, et al. Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage? Clin Rev Allergy Immunol. 2009;36(2):145–149. doi:10.1007/s12016-008-8105-y
   PubMed Web of Science ®Google Scholar
• Motegi S, Toki S, Yamada K, Uchiyama A, Ishikawa O. Elevated plasma homocysteine level is possibly associated with skin sclerosis in a series of Japanese patients with systemic sclerosis. J Dermatol. 2014;41(11):986–991. doi:10.1111/1346-8138.12642
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Canestrini S, Martinelli N, et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology. 2007;46(10):1566–1569. doi:10.1093/rheumatology/kem190
   PubMed Web of Science ®Google Scholar
• Figueroa-Méndez R, Rivas-Arancibia S. Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front Physiol. 2015;6:397. doi:10.3389/fphys.2015.00397
   PubMed Web of Science ®Google Scholar
• Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med. 2011;51(5):1000–1013. doi:10.1016/j.freeradbiomed.2011.05.017
   PubMed Web of Science ®Google Scholar
• Gilbert C. What is vitamin A and why do we need it? Community Eye Health. 2013;26(84):65.
   PubMedGoogle Scholar
• Frank LL. Thiamin in clinical practice. J Parenter Enter Nutr. 2015;39(5):503–520. doi:10.1177/0148607114565245
   PubMed Web of Science ®Google Scholar
• Lundberg AC, Akesson A, Akesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis. 1992;51(10):1143LP–1148 . doi:10.1136/ard.51.10.1143
   Web of Science ®Google Scholar
• Chan S, Gerson B, Subramaniam S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med. 1998;18(4):673–685. doi:10.1016/S0272-2712(18)30143-4
   PubMed Web of Science ®Google Scholar
• Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168(4):404–410. doi:10.1001/archinternmed.2007.74
   PubMed Web of Science ®Google Scholar
• Rasmussen LB, Schomburg L, Köhrle J, et al. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol. 2011;164(4):585–590. doi:10.1530/EJE-10-1026
   PubMed Web of Science ®Google Scholar
• Drutel A, Archambeaud F, Caron P. Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol (Oxf). 2013;78(2):155–164. doi:10.1111/cen.12066
   PubMed Web of Science ®Google Scholar
• Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84(4):762–773. doi:10.1093/ajcn/84.4.762
   PubMed Web of Science ®Google Scholar
• Sun Q, Hackler J, Hilger J, et al. Selenium and copper as biomarkers for pulmonary arterial hypertension in systemic sclerosis. Nutrients. 2020;12(6):1894. doi:10.3390/nu12061894
   PubMed Web of Science ®Google Scholar
• Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006;25(3):320–324. doi:10.1007/s10067-005-0013-4
   PubMed Web of Science ®Google Scholar
• Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19(2):164–174.
   PubMed Web of Science ®Google Scholar
• Ruiter G, Lanser IJ, Deman FS, et al. Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension. Rheumatol. 2014;53(2):285–292. doi:10.1093/rheumatology/ket331
   PubMed Web of Science ®Google Scholar
• Westerman MP, Martinez RC, Medsger TA, Totten RS, Rodnan GP. Anemia and scleroderma: frequency, causes, and marrow findings. Arch Intern Med. 1968;122(1):39–42. doi:10.1001/archinte.1968.00300060041007
   PubMedGoogle Scholar
• Ma D, Peng L. Vitamin D and pulmonary fibrosis: a review of molecular mechanisms. Int J Clin Exp Pathol. 2019;12(9):3171–3178.
   PubMed Web of Science ®Google Scholar
• Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Arterioscler Thromb Vasc Biol. 1997;17(10):2074–2081. doi:10.1161/01.ATV.17.10.2074
   PubMed Web of Science ®Google Scholar
• Perła-Kaján J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007;32(4):561–572. doi:10.1007/s00726-006-0432-9
   PubMed Web of Science ®Google Scholar
• Babitt JL. Ironing out pulmonary arterial hypertension. Proc Natl Acad Sci. 2019;116(26):12604LP–12606 . doi:10.1073/pnas.1908298116
   Web of Science ®Google Scholar
• Ostojic P, Damjanov N. Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis. Rheumatol Int. 2011;31(8):1051–1054. doi:10.1007/s00296-010-1398-1
   PubMed Web of Science ®Google Scholar
• McMahan ZH, Tucker AE, Perin J, et al. The relationship between gastrointestinal transit, Medsger GI severity, and UCLA GIT 2.0 symptoms in patients with systemic sclerosis. Arthritis Care Res. 2020. doi:10.1002/acr.24488
   Web of Science ®Google Scholar
• Herrick AL, Worthington H, Rieley F, et al. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol. 1996;23(4):650–653.
   PubMed Web of Science ®Google Scholar
• Teh LS, Johns CW, Shaffer JL, et al. Ascorbic acid absorption in patients with systemic sclerosis. J Rheumatol. 1997;24(12):2353–2357.
   PubMed Web of Science ®Google Scholar
• Türk İ, Cüzdan N, Çiftçi V, Arslan D, Doğan MC, Unal İ. Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study. Clin Rheumatol. 2020;39(1):57–67. doi:10.1007/s10067-019-04598-y
   PubMed Web of Science ®Google Scholar